

WWW.FINANCIALEXPRESS.COM
SUNDAY, JANUARY 25, 2026
19

# FE SUNDAY

## CELLA SPACE LIMITED
CIN: L93000KL1991PLC006207
57/2993-94, Sree Kailas, Pallam Road, Ernakulam, Kochi -16

### EXTRACT OF UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 31st DECEMBER 2025
(Rs in lakhs)

|PARTICULARS|STANDALONE|||
|-|-|-|-|
||Unaudited Quarter ending 31.12.2025|Unaudited 9 months Ended 31.12.2025|Unaudited Corresponding 3 months ended in previous year 31.12.2024|
|Total Income from Operations (net)|72.44|508.13|88.90|
|Net Profit/ (loss) from ordinary activities before tax|13.67|187.83|22.53|
|Net Profit/ (loss) for the period after tax|(43.48)|130.68|22.53|
|Total Comprehensive income for the period and other comprehensive income (after tax)|(43.48)|130.68|22.53|
|Equity Share capital|2,015.12|2,015.12|2,015.12|
|Reserves (Excluding revaluation reserve)|-|-|-|
|Earnings per share (Rs.10/- each)) - Basic|(0.22)|0.65|0.11|
|- Diluted|(0.22)|0.65|0.11|
|Revenue from Operations|11.69|215.40|16.89|
|Less : Direct Expenses|1.78|8.98|1.33|
|Revenue from operations (net)|9.91|206.42|15.56|


Note : The above is an extract of the detailed format of quarterly/annual financial results file with the Stock exchange and regulation 33 of the SEBI (listing and other disclosure requirements), regulations, 2015. the full format of the quarterly/annual financial results are available on the Stock exchange website www.bseindia.com.

For Cella Space Limited
Sd/-,
S Rajkumar
Vice Chairman and Managing Director

Place : Chennai
Date : 23.01.2026

## OneSource Specialty Pharma Limited
(formerly known as Stelis Biopharma Limited)
Registered Office : Unit no. 902, "Cyber One" situated at Plot no.-4 & 6, Sector 30A, Vashi, Navi Mumbai-400703
Corporate Office : Star 1, Opp IIM Bangalore, Bilekahalli, Bannerghatta Road, Bangalore - 560076, India
CIN: L74140MH2007PLC432497, Website : https://www.onesourcedmo.com, Mail: info@onesourcedmo.com

### UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2025
(₹ in Million)

||Sr No|Particulars|Consolidated||||Standalone||||
|-|-|-|-|-|-|-|-|-|-|-|
|||Quarter ended|Nine months period ended|Year ended||Quarter ended|Nine months period ended|Year ended|||
|||31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2024 (Unaudited)|31.03.2025 (Audited)|31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2025 (Unaudited)|
|1|Revenue from Operations|2,903.40|3,757.63|3,925.63|9,933.73|10,189.00|14,448.53|2,902.20|3,751.07|3,367.49|
|2|Net Profit/ (Loss) for the period (before Tax, Exceptional and/ or Extraordinary items)|(859.21)|57.41|340.21|(817.09)|(397.23)|437.79|(550.95)|371.01|275.00|
|3|Net Profit/ (Loss) for the period after tax (Before Exceptional and/ or Extraordinary items and discontinued operations)|(816.09)|104.85|316.74|(684.40)|(56.28)|935.64|(550.95)|371.01|275.00|
|4|Net Profit/ (Loss) for the period after tax (after Exceptional and/ or Extraordinary items and discontinued operation)|(886.99)|104.85|(688.49)|(784.00)|(1,164.73)|(179.71)|(621.85)|371.01|(730.23)|
|5|Earnings Per Share (of Re.1/- each) (for continuing and discontinued operations) -||||||||||
||1. Basic:|(7.74)|0.92|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|
||2. Diluted:|(7.74)|0.91|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|


Note: The above is an extract of the detailed format of the Unaudited Statement of Consolidated and Standalone Financials Results filed with the Stock Exchanges under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The full format of the Consolidated and Standalone Financials Results for the quarter and nine months ended December 31, 2025 is available on the website of Stock Exchanges at www.bseindia.com and www.nseindia.com and also on the Company's website at www.onesourcedmo.com. The same can be accessed by scanning the QR code provided below.

By order of the Board
Sd/-,
Neeraj Sharma
Managing Director
DIN: 09402652
Place: Bengaluru
Date : January 23, 2026

# nuvama
## NUVAMA WEALTH MANAGEMENT LIMITED

Corporate Identity Number : L6710MH1993PLC344634
Registered. Office: 801 - 804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051
• +91 22 6620 3030 • Website: www.nuvama.com

### Financial results for the quarter and nine months ended December 31, 2025
(₹ in Crore, except per share data)

||Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)||
|1 Total income from operations|1,105.98|1,137.93|1,034.99|3,368.52|3,044.51|4,169.30||
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|253.62|253.98|251.71|771.47|729.79|985.06||
|5 Total Comprehensive Income for the period \[Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income (after tax)]|254.66|254.49|251.66|773.50|730.66|984.52||
|6 Paid-up equity share capital (Face Value of ₹ 2/- Per Share)|36.36|36.06|35.88|36.36|35.88|35.97||
|7 Reserves (excluding Revaluation Reserves)|3,780.82|3,733.92|3,157.96|3,780.82|3,157.96|3,434.78||
|8 Securities premium account|1,698.08|1,646.40|1,615.67|1,698.08|1,615.67|1,630.59||
|9 Net worth¹|3,839.14|3,792.43|3,216.34|3,839.14|3,216.34|3,493.11||
|10 Paid-up Debt Capital / Outstanding Debt²|9,964.72|8,974.85|7,552.61|9,964.72|7,552.61|7,838.83||
|11 Outstanding redeemable preference shares|-|-|-|-|-|-||
|12 Debt Equity Ratio³|2.60|2.37|2.35|2.60|2.35|2.24||
|13 Earnings Per Share (₹) (Face Value of ₹ 2/- each)||||||||
||- Basic (Refer note 5 and 6)|14.02|14.11|14.08|42.79|41.10|55.33|
||- Diluted (Refer note 5 and 6)|13.62|13.63|13.71|41.57|40.01|53.71|
|14 Capital Redemption Reserve|20.96|20.96|20.96|20.96|20.96|20.96||
|15 Debenture Redemption Reserve|8.50|19.09|13.29|8.50|13.29|19.09||
|16 Debt Service Coverage Ratio⁴|0.06|0.06|0.07|0.16|0.19|0.25||
|17 Interest Service Coverage Ratio⁵|2.43|2.46|2.52|2.46|2.64|2.64||


¹ Net worth = Equity share capital + Other equity + Non controlling interests
² Paid-up Debt Capital / Outstanding Debt = Debt securities + Borrowings (other than debt securities)
³ Debt-equity Ratio = Total debt (Debt securities + Borrowings (other than debt securities)) / Net worth
⁴ Debt Service Coverage Ratio = (Profit before tax and Finance cost excluding IND AS 116 impact) / (Finance cost excluding IND AS 116 impact + Total Debt)
⁵ Interest Service Coverage Ratio = Profit before tax and Finance cost excluding IND AS 116 impact / Finance cost excluding IND AS 116 impact

Notes:
1. The above is an extract of the detailed format of quarter and nine months ended December 31, 2025 consolidated financial results filed with the Stock Exchanges in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the 'Listing Regulations, 2015') and the Accounting Standards specified under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the relevant provision of the Companies Act, 2013, as applicable. The full format of the standalone and consolidated financial results are available on the website of BSE Limited ('BSE') (www.bseindia.com), National Stock Exchange of India Limited ('NSE') (www.nseindia.com) and Company's website (www.nuvama.com).
2. For the other line items referred in regulation 52 (4) of the Listing Regulations, pertinent disclosures have been made to the Stock Exchanges.
3. The above consolidated financial results of the Company and its subsidiaries (together referred to as 'Group') and its associate and joint venture for the quarter and nine months ended December 31, 2025 have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meetings held on January 23, 2026.
4. The above consolidated financial results for the quarter and nine months ended December 31, 2025 have been subjected to limited review by the Statutory Auditors of the Company and the auditors have issued an unmodified review report.
5. Earnings per share for the quarter and nine months ended are not annualised.
6. The Board of Directors of the Company, at its meeting held on November 04, 2025, approved the sub-division of each equity share having a face value of ₹10/- (Rupees Ten only), fully paid-up, into 5 (five) equity shares having a face value of ₹2/- (Rupees Two only), fully paid-up. Subsequently, the approval of the shareholders was obtained through a postal ballot on December 07, 2025. Consequently, with effect from the Record Date of December 26, 2025, the authorised share capital and paid-up share capital of the Company have been sub-divided into equity shares of face value ₹2/- each. The Earnings Per Share (EPS) for the current and comparative periods have been adjusted/restated appropriately.
7. Standalone financial information of the Company, pursuant to regulation 47(1)(b) of the Listing Regulations, 2015.

(₹ in Crore, except per share data)

|Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)|
|1 Total income from operations|406.50|192.01|385.35|1,024.16|1,136.83|1,357.24|
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|280.29|46.35|206.86|548.12|570.24|597.71|


For and on behalf of the Board of Directors
Sd/-
Ashish Kehair
Managing Director & CEO
DIN: 07789972

Mumbai, January 23, 2026

## PULSAR INTERNATIONAL LIMITED
CORPORATE IDENTIFICATION NUMBER: L46209GJ1990PLC152223

Our Company was originally incorporated as "Arlabs International Private Limited" under the provisions of the Companies Act, 1956, pursuant to a Certificate of Incorporation dated October 15, 1990, issued by the Registrar of Companies, Bombay, Maharashtra. The Company was subsequently converted into a Public Limited Company under the name "Arlabs International Limited", pursuant to a Certificate of Change of Name issued on December 06, 1993 by the Registrar of Companies, Bombay, Maharashtra. The Equity Shares of the Company were listed and admitted to dealings on the Capital Market Segment (Main Board) of BSE Limited on September 26, 1994. Thereafter, the name of the Company was changed to "Pulsar International Limited", pursuant to a Fresh Certificate of Incorporation consequent upon change of name dated May 10, 1996, issued by the Registrar of Companies, Maharashtra. Further, the Registered Office of the Company was shifted from the "State of Maharashtra" to "State of Gujarat" pursuant to an order dated April 26, 2024, passed by the Regional Director and the consequent Certificate of Registration of Regional Director order for change of State dated June 05, 2024, issued by the Registrar of Companies, Ahmedabad. For further details of our Company, please refer to the chapter titled "General Information" on page no. 37 of the Letter of Offer.

Registered Office: 16 Vibrant Mega Industrial Park Survey No. 33, Mouje Vehlal Taluka Daskroi, Vehlal, Ahmedabad, Gujarat, India - 382330
Contact No.: +91-72028 53326, Email id: pulsar.intltd@gmail.com; Website: www.pulsarinternational.co.in;
Contact Person: Ms. Bhumi Sagar Mehta, Company Secretary and Compliance Officer

### OUR PROMOTERS: M/S. BLUEROCK INVESTMENT QUOTIENT LLP

ISSUE OF UPTO 35,69,50,000# FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF RE. 1.00/- EACH ("EQUITY SHARES") OF PULSAR INTERNATIONAL LIMITED ("PULSAR" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RE. 1.00/- PER EQUITY SHARE ("ISSUE PRICE"), AGGREGATING UPTO RS. 35.695 CRORES ON A RIGHTS BASIS TO THE EXISTING EQUITY SHAREHOLDERS OF OUR COMPANY IN THE RATIO OF 5 (FIVE) RIGHTS EQUITY SHARES FOR EVERY 1 (ONE) FULLY PAID-UP EQUITY SHARE HELD BY THE ELIGIBLE EQUITY SHAREHOLDERS ON THE RECORD DATE, MONDAY, 22ND DECEMBER, 2025 (THE "RECORD DATE"). THE ISSUE PRICE IS EQUAL TO THE FACE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE SEE THE CHAPTER TITLED "TERMS OF THE ISSUE" ON PAGE NO. 135 OF THE LETTER OF OFFER.

#ASSUMING FULL SUBSCRIPTION OF THE ISSUE SUBJECT TO FINALISATION OF BASIS OF ALLOTMENT.

### BASIS OF ALLOTMENT

The Board of Directors of our Company thanks all investors for their response to the Issue, which opened for subscription on Wednesday, 31st December, 2025 and closed on Monday, 19th January, 2026 and the last date for On-Market Renunciation of Rights Entitlements was Tuesday, 13th January, 2026. Out of the total 2961 Applications for 46,23,20,738 Rights Equity Shares, 988 Applications for 33,78,888 Rights Equity Shares were rejected due to technical reason, Nil Rights Equity Shares were partially rejected as disclosed in the Basis of allotment approved by BSE Limited ('BSE'). The total number of valid Applications received were 1,973 Applications for 45,89,41,850 Rights Equity Shares. Final subscription is 128.57% after removing rejection of Rights Equity Shares under the Issue.

In accordance with the Letter of Offer and the Basis of Allotment finalized on 21st January, 2026, in consultation with the Registrar to the Issue ('RTA') and BSE Limited ('BSE'), the Designated Stock Exchange, the Rights Issue Committee allotted 35,69,50,000 Fully Paid-up Rights Equity Shares on 21st January, 2026 to the successful Applicants. All valid Applications have been considered for allotment.

1. The break-up of valid applications received through ASBA is as under:

|Applicants|No. of applicants|No. of Equity Shares allotted against REs|No. of Rights Equity Shares allotted against valid additional shares|Total Equity Shares allotted|
|-|-|-|-|-|
|Eligible Equity Shareholders|1,675|4,00,08,625|5,06,35,625|9,06,44,251|
|Renouncees|298|2,21,51,661|24,41,54,088|26,63,05,749|
|\*\*Total\*\*|\*\*1,973\*\*|\*\*6,21,60,287\*\*|\*\*29,47,89,713\*\*|\*\*356,9,50,000\*\*|


2. Information regarding total applications received
Summary of Allotment in various categories is as under:

|Category|Gross|||Less: Rejections / Partial Amount|||Valid|||
|-|-|-|-|-|-|-|-|-|-|
||Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|
|Eligible Equity Shareholders|1,724|9,12,24,685|9,12,24,685.00|49|5,80,434|5,80,434.00|1,675|90,64,4251|90,64,4251.00|
|Fraction|0|0|0.00|0|0|0.00|0|0|0.00|
|Renouncees|308|3,68,419,099|36,84,19,099.00|10|1,21,500|1,21,500.00|298|36,82,97,599|36,82,97,599.00|
|Not an eligible equity Shareholders of the company|929|26,76,954|26,76,954.00|929|26,76,954|26,76,954.00|0|0|0|
|\*\*Total\*\*|\*\*2,961\*\*|\*\*46,23,20,738\*\*|\*\*46,23,20,738.00\*\*|\*\*988\*\*|\*\*33,78,888\*\*|\*\*33,78,888.00\*\*|\*\*1,973\*\*|\*\*45,89,41,850\*\*|\*\*1,39,03,47,024.00\*\*|


Intimation for Allotment/ refund/ rejection cases: The dispatch of allotment advice cum refund intimation and intimation for rejection, as applicable, to the Investors has been completed on 22nd January, 2026. The instructions to SCSBs for unblocking of funds were given on, 21st January, 2026. The listing application was filed with BSE on 22nd January, 2026 and subsequently, the listing approval was received on 22nd January, 2026 from BSE. The credit of Rights Equity Shares in dematerialised form to respective demat accounts of Allottees was completed on 22nd January, 2026 by CDSL and NSDL respectively. For further details, see "Terms of the Issue - Allotment advice or refund/unblocking of ASBA accounts" on page no. 159 of the Letter of Offer. The trading in fully paid-up equity shares issued by way of Rights shall commence on BSE under ISIN - INE183U01022 upon receipt of trading permission. The trading is expected to commence on or about 28th January, 2026.

Further, in accordance with SEBI circular bearing reference - SEBI/HO/CFD/DIL2/CIR/P/2020/13 dated January 22, 2020, the request for extinguishment of Rights Entitlements has been sent to NSDL & CDSL on or before 22nd January, 2026.

**INVESTORS MAY PLEASE NOTE THAT THE EQUITY SHARES CAN BE TRADED ON THE STOCK EXCHANGE IN DEMATERIALISED FORM**

**DISCLAIMER CLAUSE OF BSE (DESIGNATED STOCK EXCHANGE):** It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the Letter of Offer has been cleared or approved by BSE Limited, nor does it certify the correctness or completeness of any of the contents of the Letter of Offer. The investors are advised to refer to the Letter of Offer for the full text of the "Disclaimer Clause of BSE" on page no. 130 of the Letter of Offer.

Unless otherwise specified, all capitalized terms used herein shall have same meaning ascribed to such terms in the Letter of Offer.

|REGISTRAR TO THE ISSUE|COMPANY SECRETARY AND COMPLIANCE OFFICER|
|-|-|


| :--- | :---


WWW.FINANCIALEXPRESS.COM
SUNDAY, JANUARY 25, 2026
19

# FE SUNDAY

## CELLA SPACE LIMITED
CIN: L93000KL1991PLC006207
57/2993-94, Sree Kailas, Pallam Road, Ernakulam, Kochi -16

### EXTRACT OF UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 31st DECEMBER 2025
(Rs in lakhs)

|PARTICULARS|STANDALONE|||
|-|-|-|-|
||Unaudited Quarter ending 31.12.2025|Unaudited 9 months Ended 31.12.2025|Unaudited Corresponding 3 months ended in previous year 31.12.2024|
|Total Income from Operations (net)|72.44|508.13|88.90|
|Net Profit/ (loss) from ordinary activities before tax|13.67|187.83|22.53|
|Net Profit/ (loss) for the period after tax|(43.48)|130.68|22.53|
|Total Comprehensive income for the period and other comprehensive income (after tax)|(43.48)|130.68|22.53|
|Equity Share capital|2,015.12|2,015.12|2,015.12|
|Reserves (Excluding revaluation reserve)|-|-|-|
|Earnings per share (Rs.10/- each)) - Basic|(0.22)|0.65|0.11|
|- Diluted|(0.22)|0.65|0.11|
|Revenue from Operations|11.69|215.40|16.89|
|Less : Direct Expenses|1.78|8.98|1.33|
|Revenue from operations (net)|9.91|206.42|15.56|


Note : The above is an extract of the detailed format of quarterly/annual financial results file with the Stock exchange and regulation 33 of the SEBI (listing and other disclosure requirements), regulations, 2015. the full format of the quarterly/annual financial results are available on the Stock exchange website www.bseindia.com.

For Cella Space Limited
Sd/-,
S Rajkumar
Vice Chairman and Managing Director

Place : Chennai
Date : 23.01.2026

## OneSource Specialty Pharma Limited
(formerly known as Stelis Biopharma Limited)
Registered Office : Unit no. 902, "Cyber One" situated at Plot no.-4 & 6, Sector 30A, Vashi, Navi Mumbai-400703
Corporate Office : Star 1, Opp IIM Bangalore, Bilekahalli, Bannerghatta Road, Bangalore - 560076, India
CIN: L74140MH2007PLC432497, Website : https://www.onesourcedmo.com, Mail: info@onesourcedmo.com

### UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2025
(₹ in Million)

||Sr No|Particulars|Consolidated||||Standalone||||
|-|-|-|-|-|-|-|-|-|-|-|
|||Quarter ended|Nine months period ended|Year ended||Quarter ended|Nine months period ended|Year ended|||
|||31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2024 (Unaudited)|31.03.2025 (Audited)|31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2025 (Unaudited)|
|1|Revenue from Operations|2,903.40|3,757.63|3,925.63|9,933.73|10,189.00|14,448.53|2,902.20|3,751.07|3,367.49|
|2|Net Profit/ (Loss) for the period (before Tax, Exceptional and/ or Extraordinary items)|(859.21)|57.41|340.21|(817.09)|(397.23)|437.79|(550.95)|371.01|275.00|
|3|Net Profit/ (Loss) for the period after tax (Before Exceptional and/ or Extraordinary items and discontinued operations)|(816.09)|104.85|316.74|(684.40)|(56.28)|935.64|(550.95)|371.01|275.00|
|4|Net Profit/ (Loss) for the period after tax (after Exceptional and/ or Extraordinary items and discontinued operation)|(886.99)|104.85|(688.49)|(784.00)|(1,164.73)|(179.71)|(621.85)|371.01|(730.23)|
|5|Earnings Per Share (of Re.1/- each) (for continuing and discontinued operations) -||||||||||
||1. Basic:|(7.74)|0.92|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|
||2. Diluted:|(7.74)|0.91|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|


Note: The above is an extract of the detailed format of the Unaudited Statement of Consolidated and Standalone Financials Results filed with the Stock Exchanges under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The full format of the Consolidated and Standalone Financials Results for the quarter and nine months ended December 31, 2025 is available on the website of Stock Exchanges at www.bseindia.com and www.nseindia.com and also on the Company's website at www.onesourcedmo.com. The same can be accessed by scanning the QR code provided below.

By order of the Board
Sd/-,
Neeraj Sharma
Managing Director
DIN: 09402652
Place: Bengaluru
Date : January 23, 2026

# nuvama
## NUVAMA WEALTH MANAGEMENT LIMITED

Corporate Identity Number : L6710MH1993PLC344634
Registered. Office: 801 - 804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051
• +91 22 6620 3030 • Website: www.nuvama.com

### Financial results for the quarter and nine months ended December 31, 2025
(₹ in Crore, except per share data)

||Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)||
|1 Total income from operations|1,105.98|1,137.93|1,034.99|3,368.52|3,044.51|4,169.30||
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|253.62|253.98|251.71|771.47|729.79|985.06||
|5 Total Comprehensive Income for the period \[Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income (after tax)]|254.66|254.49|251.66|773.50|730.66|984.52||
|6 Paid-up equity share capital (Face Value of ₹ 2/- Per Share)|36.36|36.06|35.88|36.36|35.88|35.97||
|7 Reserves (excluding Revaluation Reserves)|3,780.82|3,733.92|3,157.96|3,780.82|3,157.96|3,434.78||
|8 Securities premium account|1,698.08|1,646.40|1,615.67|1,698.08|1,615.67|1,630.59||
|9 Net worth¹|3,839.14|3,792.43|3,216.34|3,839.14|3,216.34|3,493.11||
|10 Paid-up Debt Capital / Outstanding Debt²|9,964.72|8,974.85|7,552.61|9,964.72|7,552.61|7,838.83||
|11 Outstanding redeemable preference shares|-|-|-|-|-|-||
|12 Debt Equity Ratio³|2.60|2.37|2.35|2.60|2.35|2.24||
|13 Earnings Per Share (₹) (Face Value of ₹ 2/- each)||||||||
||- Basic (Refer note 5 and 6)|14.02|14.11|14.08|42.79|41.10|55.33|
||- Diluted (Refer note 5 and 6)|13.62|13.63|13.71|41.57|40.01|53.71|
|14 Capital Redemption Reserve|20.96|20.96|20.96|20.96|20.96|20.96||
|15 Debenture Redemption Reserve|8.50|19.09|13.29|8.50|13.29|19.09||
|16 Debt Service Coverage Ratio⁴|0.06|0.06|0.07|0.16|0.19|0.25||
|17 Interest Service Coverage Ratio⁵|2.43|2.46|2.52|2.46|2.64|2.64||


¹ Net worth = Equity share capital + Other equity + Non controlling interests
² Paid-up Debt Capital / Outstanding Debt = Debt securities + Borrowings (other than debt securities)
³ Debt-equity Ratio = Total debt (Debt securities + Borrowings (other than debt securities)) / Net worth
⁴ Debt Service Coverage Ratio = (Profit before tax and Finance cost excluding IND AS 116 impact) / (Finance cost excluding IND AS 116 impact + Total Debt)
⁵ Interest Service Coverage Ratio = Profit before tax and Finance cost excluding IND AS 116 impact / Finance cost excluding IND AS 116 impact

Notes:
1. The above is an extract of the detailed format of quarter and nine months ended December 31, 2025 consolidated financial results filed with the Stock Exchanges in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the 'Listing Regulations, 2015') and the Accounting Standards specified under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the relevant provision of the Companies Act, 2013, as applicable. The full format of the standalone and consolidated financial results are available on the website of BSE Limited ('BSE') (www.bseindia.com), National Stock Exchange of India Limited ('NSE') (www.nseindia.com) and Company's website (www.nuvama.com).
2. For the other line items referred in regulation 52 (4) of the Listing Regulations, pertinent disclosures have been made to the Stock Exchanges.
3. The above consolidated financial results of the Company and its subsidiaries (together referred to as 'Group') and its associate and joint venture for the quarter and nine months ended December 31, 2025 have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meetings held on January 23, 2026.
4. The above consolidated financial results for the quarter and nine months ended December 31, 2025 have been subjected to limited review by the Statutory Auditors of the Company and the auditors have issued an unmodified review report.
5. Earnings per share for the quarter and nine months ended are not annualised.
6. The Board of Directors of the Company, at its meeting held on November 04, 2025, approved the sub-division of each equity share having a face value of ₹10/- (Rupees Ten only), fully paid-up, into 5 (five) equity shares having a face value of ₹2/- (Rupees Two only), fully paid-up. Subsequently, the approval of the shareholders was obtained through a postal ballot on December 07, 2025. Consequently, with effect from the Record Date of December 26, 2025, the authorised share capital and paid-up share capital of the Company have been sub-divided into equity shares of face value ₹2/- each. The Earnings Per Share (EPS) for the current and comparative periods have been adjusted/restated appropriately.
7. Standalone financial information of the Company, pursuant to regulation 47(1)(b) of the Listing Regulations, 2015.

(₹ in Crore, except per share data)

|Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)|
|1 Total income from operations|406.50|192.01|385.35|1,024.16|1,136.83|1,357.24|
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|280.29|46.35|206.86|548.12|570.24|597.71|


For and on behalf of the Board of Directors
Sd/-
Ashish Kehair
Managing Director & CEO
DIN: 07789972

Mumbai, January 23, 2026

## PULSAR INTERNATIONAL LIMITED
CORPORATE IDENTIFICATION NUMBER: L46209GJ1990PLC152223

Our Company was originally incorporated as "Arlabs International Private Limited" under the provisions of the Companies Act, 1956, pursuant to a Certificate of Incorporation dated October 15, 1990, issued by the Registrar of Companies, Bombay, Maharashtra. The Company was subsequently converted into a Public Limited Company under the name "Arlabs International Limited", pursuant to a Certificate of Change of Name issued on December 06, 1993 by the Registrar of Companies, Bombay, Maharashtra. The Equity Shares of the Company were listed and admitted to dealings on the Capital Market Segment (Main Board) of BSE Limited on September 26, 1994. Thereafter, the name of the Company was changed to "Pulsar International Limited", pursuant to a Fresh Certificate of Incorporation consequent upon change of name dated May 10, 1996, issued by the Registrar of Companies, Maharashtra. Further, the Registered Office of the Company was shifted from the "State of Maharashtra" to "State of Gujarat" pursuant to an order dated April 26, 2024, passed by the Regional Director and the consequent Certificate of Registration of Regional Director order for change of State dated June 05, 2024, issued by the Registrar of Companies, Ahmedabad. For further details of our Company, please refer to the chapter titled "General Information" on page no. 37 of the Letter of Offer.

Registered Office: 16 Vibrant Mega Industrial Park Survey No. 33, Mouje Vehlal Taluka Daskroi, Vehlal, Ahmedabad, Gujarat, India - 382330
Contact No.: +91-72028 53326, Email id: pulsar.intltd@gmail.com; Website: www.pulsarinternational.co.in;
Contact Person: Ms. Bhumi Sagar Mehta, Company Secretary and Compliance Officer

### OUR PROMOTERS: M/S. BLUEROCK INVESTMENT QUOTIENT LLP

ISSUE OF UPTO 35,69,50,000# FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF RE. 1.00/- EACH ("EQUITY SHARES") OF PULSAR INTERNATIONAL LIMITED ("PULSAR" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RE. 1.00/- PER EQUITY SHARE ("ISSUE PRICE"), AGGREGATING UPTO RS. 35.695 CRORES ON A RIGHTS BASIS TO THE EXISTING EQUITY SHAREHOLDERS OF OUR COMPANY IN THE RATIO OF 5 (FIVE) RIGHTS EQUITY SHARES FOR EVERY 1 (ONE) FULLY PAID-UP EQUITY SHARE HELD BY THE ELIGIBLE EQUITY SHAREHOLDERS ON THE RECORD DATE, MONDAY, 22ND DECEMBER, 2025 (THE "RECORD DATE"). THE ISSUE PRICE IS EQUAL TO THE FACE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE SEE THE CHAPTER TITLED "TERMS OF THE ISSUE" ON PAGE NO. 135 OF THE LETTER OF OFFER.

#ASSUMING FULL SUBSCRIPTION OF THE ISSUE SUBJECT TO FINALISATION OF BASIS OF ALLOTMENT.

### BASIS OF ALLOTMENT

The Board of Directors of our Company thanks all investors for their response to the Issue, which opened for subscription on Wednesday, 31st December, 2025 and closed on Monday, 19th January, 2026 and the last date for On-Market Renunciation of Rights Entitlements was Tuesday, 13th January, 2026. Out of the total 2961 Applications for 46,23,20,738 Rights Equity Shares, 988 Applications for 33,78,888 Rights Equity Shares were rejected due to technical reason, Nil Rights Equity Shares were partially rejected as disclosed in the Basis of allotment approved by BSE Limited ('BSE'). The total number of valid Applications received were 1,973 Applications for 45,89,41,850 Rights Equity Shares. Final subscription is 128.57% after removing rejection of Rights Equity Shares under the Issue.

In accordance with the Letter of Offer and the Basis of Allotment finalized on 21st January, 2026, in consultation with the Registrar to the Issue ('RTA') and BSE Limited ('BSE'), the Designated Stock Exchange, the Rights Issue Committee allotted 35,69,50,000 Fully Paid-up Rights Equity Shares on 21st January, 2026 to the successful Applicants. All valid Applications have been considered for allotment.

1. The break-up of valid applications received through ASBA is as under:

|Applicants|No. of applicants|No. of Equity Shares allotted against REs|No. of Rights Equity Shares allotted against valid additional shares|Total Equity Shares allotted|
|-|-|-|-|-|
|Eligible Equity Shareholders|1,675|4,00,08,625|5,06,35,625|9,06,44,251|
|Renouncees|298|2,21,51,661|24,41,54,088|26,63,05,749|
|\*\*Total\*\*|\*\*1,973\*\*|\*\*6,21,60,287\*\*|\*\*29,47,89,713\*\*|\*\*356,9,50,000\*\*|


2. Information regarding total applications received
Summary of Allotment in various categories is as under:

|Category|Gross|||Less: Rejections / Partial Amount|||Valid|||
|-|-|-|-|-|-|-|-|-|-|
||Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|
|Eligible Equity Shareholders|1,724|9,12,24,685|9,12,24,685.00|49|5,80,434|5,80,434.00|1,675|90,64,4251|90,64,4251.00|
|Fraction|0|0|0.00|0|0|0.00|0|0|0.00|
|Renouncees|308|3,68,419,099|36,84,19,099.00|10|1,21,500|1,21,500.00|298|36,82,97,599|36,82,97,599.00|
|Not an eligible equity Shareholders of the company|929|26,76,954|26,76,954.00|929|26,76,954|26,76,954.00|0|0|0|
|\*\*Total\*\*|\*\*2,961\*\*|\*\*46,23,20,738\*\*|\*\*46,23,20,738.00\*\*|\*\*988\*\*|\*\*33,78,888\*\*|\*\*33,78,888.00\*\*|\*\*1,973\*\*|\*\*45,89,41,850\*\*|\*\*1,39,03,47,024.00\*\*|


Intimation for Allotment/ refund/ rejection cases: The dispatch of allotment advice cum refund intimation and intimation for rejection, as applicable, to the Investors has been completed on 22nd January, 2026. The instructions to SCSBs for unblocking of funds were given on, 21st January, 2026. The listing application was filed with BSE on 22nd January, 2026 and subsequently, the listing approval was received on 22nd January, 2026 from BSE. The credit of Rights Equity Shares in dematerialised form to respective demat accounts of Allottees was completed on 22nd January, 2026 by CDSL and NSDL respectively. For further details, see "Terms of the Issue - Allotment advice or refund/unblocking of ASBA accounts" on page no. 159 of the Letter of Offer. The trading in fully paid-up equity shares issued by way of Rights shall commence on BSE under ISIN - INE183U01022 upon receipt of trading permission. The trading is expected to commence on or about 28th January, 2026.

Further, in accordance with SEBI circular bearing reference - SEBI/HO/CFD/DIL2/CIR/P/2020/13 dated January 22, 2020, the request for extinguishment of Rights Entitlements has been sent to NSDL & CDSL on or before 22nd January, 2026.

**INVESTORS MAY PLEASE NOTE THAT THE EQUITY SHARES CAN BE TRADED ON THE STOCK EXCHANGE IN DEMATERIALISED FORM**

**DISCLAIMER CLAUSE OF BSE (DESIGNATED STOCK EXCHANGE):** It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the Letter of Offer has been cleared or approved by BSE Limited, nor does it certify the correctness or completeness of any of the contents of the Letter of Offer. The investors are advised to refer to the Letter of Offer for the full text of the "Disclaimer Clause of BSE" on page no. 130 of the Letter of Offer.

Unless otherwise specified, all capitalized terms used herein shall have same meaning ascribed to such terms in the Letter of Offer.

|REGISTRAR TO THE ISSUE|COMPANY SECRETARY AND COMPLIANCE OFFICER|
|-|-|


| :--- | :---


WWW.FINANCIALEXPRESS.COM
SUNDAY, JANUARY 25, 2026
19

# FE SUNDAY

## CELLA SPACE LIMITED
CIN: L93000KL1991PLC006207
57/2993-94, Sree Kailas, Pallam Road, Ernakulam, Kochi -16

### EXTRACT OF UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 31st DECEMBER 2025
(Rs in lakhs)

|PARTICULARS|STANDALONE|||
|-|-|-|-|
||Unaudited Quarter ending 31.12.2025|Unaudited 9 months Ended 31.12.2025|Unaudited Corresponding 3 months ended in previous year 31.12.2024|
|Total Income from Operations (net)|72.44|508.13|88.90|
|Net Profit/ (loss) from ordinary activities before tax|13.67|187.83|22.53|
|Net Profit/ (loss) for the period after tax|(43.48)|130.68|22.53|
|Total Comprehensive income for the period and other comprehensive income (after tax)|(43.48)|130.68|22.53|
|Equity Share capital|2,015.12|2,015.12|2,015.12|
|Reserves (Excluding revaluation reserve)|-|-|-|
|Earnings per share (Rs.10/- each)) - Basic|(0.22)|0.65|0.11|
|- Diluted|(0.22)|0.65|0.11|
|Revenue from Operations|11.69|215.40|16.89|
|Less : Direct Expenses|1.78|8.98|1.33|
|Revenue from operations (net)|9.91|206.42|15.56|


Note : The above is an extract of the detailed format of quarterly/annual financial results file with the Stock exchange and regulation 33 of the SEBI (listing and other disclosure requirements), regulations, 2015. the full format of the quarterly/annual financial results are available on the Stock exchange website www.bseindia.com.

For Cella Space Limited
Sd/-,
S Rajkumar
Vice Chairman and Managing Director

Place : Chennai
Date : 23.01.2026

## OneSource Specialty Pharma Limited
(formerly known as Stelis Biopharma Limited)
Registered Office : Unit no. 902, "Cyber One" situated at Plot no.-4 & 6, Sector 30A, Vashi, Navi Mumbai-400703
Corporate Office : Star 1, Opp IIM Bangalore, Bilekahalli, Bannerghatta Road, Bangalore - 560076, India
CIN: L74140MH2007PLC432497, Website : https://www.onesourcedmo.com, Mail: info@onesourcedmo.com

### UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2025
(₹ in Million)

||Sr No|Particulars|Consolidated||||Standalone||||
|-|-|-|-|-|-|-|-|-|-|-|
|||Quarter ended|Nine months period ended|Year ended||Quarter ended|Nine months period ended|Year ended|||
|||31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2024 (Unaudited)|31.03.2025 (Audited)|31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2025 (Unaudited)|
|1|Revenue from Operations|2,903.40|3,757.63|3,925.63|9,933.73|10,189.00|14,448.53|2,902.20|3,751.07|3,367.49|
|2|Net Profit/ (Loss) for the period (before Tax, Exceptional and/ or Extraordinary items)|(859.21)|57.41|340.21|(817.09)|(397.23)|437.79|(550.95)|371.01|275.00|
|3|Net Profit/ (Loss) for the period after tax (Before Exceptional and/ or Extraordinary items and discontinued operations)|(816.09)|104.85|316.74|(684.40)|(56.28)|935.64|(550.95)|371.01|275.00|
|4|Net Profit/ (Loss) for the period after tax (after Exceptional and/ or Extraordinary items and discontinued operation)|(886.99)|104.85|(688.49)|(784.00)|(1,164.73)|(179.71)|(621.85)|371.01|(730.23)|
|5|Earnings Per Share (of Re.1/- each) (for continuing and discontinued operations) -||||||||||
||1. Basic:|(7.74)|0.92|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|
||2. Diluted:|(7.74)|0.91|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|


Note: The above is an extract of the detailed format of the Unaudited Statement of Consolidated and Standalone Financials Results filed with the Stock Exchanges under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The full format of the Consolidated and Standalone Financials Results for the quarter and nine months ended December 31, 2025 is available on the website of Stock Exchanges at www.bseindia.com and www.nseindia.com and also on the Company's website at www.onesourcedmo.com. The same can be accessed by scanning the QR code provided below.

By order of the Board
Sd/-,
Neeraj Sharma
Managing Director
DIN: 09402652
Place: Bengaluru
Date : January 23, 2026

# nuvama
## NUVAMA WEALTH MANAGEMENT LIMITED

Corporate Identity Number : L6710MH1993PLC344634
Registered. Office: 801 - 804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051
• +91 22 6620 3030 • Website: www.nuvama.com

### Financial results for the quarter and nine months ended December 31, 2025
(₹ in Crore, except per share data)

||Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)||
|1 Total income from operations|1,105.98|1,137.93|1,034.99|3,368.52|3,044.51|4,169.30||
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|253.62|253.98|251.71|771.47|729.79|985.06||
|5 Total Comprehensive Income for the period \[Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income (after tax)]|254.66|254.49|251.66|773.50|730.66|984.52||
|6 Paid-up equity share capital (Face Value of ₹ 2/- Per Share)|36.36|36.06|35.88|36.36|35.88|35.97||
|7 Reserves (excluding Revaluation Reserves)|3,780.82|3,733.92|3,157.96|3,780.82|3,157.96|3,434.78||
|8 Securities premium account|1,698.08|1,646.40|1,615.67|1,698.08|1,615.67|1,630.59||
|9 Net worth¹|3,839.14|3,792.43|3,216.34|3,839.14|3,216.34|3,493.11||
|10 Paid-up Debt Capital / Outstanding Debt²|9,964.72|8,974.85|7,552.61|9,964.72|7,552.61|7,838.83||
|11 Outstanding redeemable preference shares|-|-|-|-|-|-||
|12 Debt Equity Ratio³|2.60|2.37|2.35|2.60|2.35|2.24||
|13 Earnings Per Share (₹) (Face Value of ₹ 2/- each)||||||||
||- Basic (Refer note 5 and 6)|14.02|14.11|14.08|42.79|41.10|55.33|
||- Diluted (Refer note 5 and 6)|13.62|13.63|13.71|41.57|40.01|53.71|
|14 Capital Redemption Reserve|20.96|20.96|20.96|20.96|20.96|20.96||
|15 Debenture Redemption Reserve|8.50|19.09|13.29|8.50|13.29|19.09||
|16 Debt Service Coverage Ratio⁴|0.06|0.06|0.07|0.16|0.19|0.25||
|17 Interest Service Coverage Ratio⁵|2.43|2.46|2.52|2.46|2.64|2.64||


¹ Net worth = Equity share capital + Other equity + Non controlling interests
² Paid-up Debt Capital / Outstanding Debt = Debt securities + Borrowings (other than debt securities)
³ Debt-equity Ratio = Total debt (Debt securities + Borrowings (other than debt securities)) / Net worth
⁴ Debt Service Coverage Ratio = (Profit before tax and Finance cost excluding IND AS 116 impact) / (Finance cost excluding IND AS 116 impact + Total Debt)
⁵ Interest Service Coverage Ratio = Profit before tax and Finance cost excluding IND AS 116 impact / Finance cost excluding IND AS 116 impact

Notes:
1. The above is an extract of the detailed format of quarter and nine months ended December 31, 2025 consolidated financial results filed with the Stock Exchanges in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the 'Listing Regulations, 2015') and the Accounting Standards specified under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the relevant provision of the Companies Act, 2013, as applicable. The full format of the standalone and consolidated financial results are available on the website of BSE Limited ('BSE') (www.bseindia.com), National Stock Exchange of India Limited ('NSE') (www.nseindia.com) and Company's website (www.nuvama.com).
2. For the other line items referred in regulation 52 (4) of the Listing Regulations, pertinent disclosures have been made to the Stock Exchanges.
3. The above consolidated financial results of the Company and its subsidiaries (together referred to as 'Group') and its associate and joint venture for the quarter and nine months ended December 31, 2025 have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meetings held on January 23, 2026.
4. The above consolidated financial results for the quarter and nine months ended December 31, 2025 have been subjected to limited review by the Statutory Auditors of the Company and the auditors have issued an unmodified review report.
5. Earnings per share for the quarter and nine months ended are not annualised.
6. The Board of Directors of the Company, at its meeting held on November 04, 2025, approved the sub-division of each equity share having a face value of ₹10/- (Rupees Ten only), fully paid-up, into 5 (five) equity shares having a face value of ₹2/- (Rupees Two only), fully paid-up. Subsequently, the approval of the shareholders was obtained through a postal ballot on December 07, 2025. Consequently, with effect from the Record Date of December 26, 2025, the authorised share capital and paid-up share capital of the Company have been sub-divided into equity shares of face value ₹2/- each. The Earnings Per Share (EPS) for the current and comparative periods have been adjusted/restated appropriately.
7. Standalone financial information of the Company, pursuant to regulation 47(1)(b) of the Listing Regulations, 2015.

(₹ in Crore, except per share data)

|Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)|
|1 Total income from operations|406.50|192.01|385.35|1,024.16|1,136.83|1,357.24|
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|280.29|46.35|206.86|548.12|570.24|597.71|


For and on behalf of the Board of Directors
Sd/-
Ashish Kehair
Managing Director & CEO
DIN: 07789972

Mumbai, January 23, 2026

## PULSAR INTERNATIONAL LIMITED
CORPORATE IDENTIFICATION NUMBER: L46209GJ1990PLC152223

Our Company was originally incorporated as "Arlabs International Private Limited" under the provisions of the Companies Act, 1956, pursuant to a Certificate of Incorporation dated October 15, 1990, issued by the Registrar of Companies, Bombay, Maharashtra. The Company was subsequently converted into a Public Limited Company under the name "Arlabs International Limited", pursuant to a Certificate of Change of Name issued on December 06, 1993 by the Registrar of Companies, Bombay, Maharashtra. The Equity Shares of the Company were listed and admitted to dealings on the Capital Market Segment (Main Board) of BSE Limited on September 26, 1994. Thereafter, the name of the Company was changed to "Pulsar International Limited", pursuant to a Fresh Certificate of Incorporation consequent upon change of name dated May 10, 1996, issued by the Registrar of Companies, Maharashtra. Further, the Registered Office of the Company was shifted from the "State of Maharashtra" to "State of Gujarat" pursuant to an order dated April 26, 2024, passed by the Regional Director and the consequent Certificate of Registration of Regional Director order for change of State dated June 05, 2024, issued by the Registrar of Companies, Ahmedabad. For further details of our Company, please refer to the chapter titled "General Information" on page no. 37 of the Letter of Offer.

Registered Office: 16 Vibrant Mega Industrial Park Survey No. 33, Mouje Vehlal Taluka Daskroi, Vehlal, Ahmedabad, Gujarat, India - 382330
Contact No.: +91-72028 53326, Email id: pulsar.intltd@gmail.com; Website: www.pulsarinternational.co.in;
Contact Person: Ms. Bhumi Sagar Mehta, Company Secretary and Compliance Officer

### OUR PROMOTERS: M/S. BLUEROCK INVESTMENT QUOTIENT LLP

ISSUE OF UPTO 35,69,50,000# FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF RE. 1.00/- EACH ("EQUITY SHARES") OF PULSAR INTERNATIONAL LIMITED ("PULSAR" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RE. 1.00/- PER EQUITY SHARE ("ISSUE PRICE"), AGGREGATING UPTO RS. 35.695 CRORES ON A RIGHTS BASIS TO THE EXISTING EQUITY SHAREHOLDERS OF OUR COMPANY IN THE RATIO OF 5 (FIVE) RIGHTS EQUITY SHARES FOR EVERY 1 (ONE) FULLY PAID-UP EQUITY SHARE HELD BY THE ELIGIBLE EQUITY SHAREHOLDERS ON THE RECORD DATE, MONDAY, 22ND DECEMBER, 2025 (THE "RECORD DATE"). THE ISSUE PRICE IS EQUAL TO THE FACE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE SEE THE CHAPTER TITLED "TERMS OF THE ISSUE" ON PAGE NO. 135 OF THE LETTER OF OFFER.

#ASSUMING FULL SUBSCRIPTION OF THE ISSUE SUBJECT TO FINALISATION OF BASIS OF ALLOTMENT.

### BASIS OF ALLOTMENT

The Board of Directors of our Company thanks all investors for their response to the Issue, which opened for subscription on Wednesday, 31st December, 2025 and closed on Monday, 19th January, 2026 and the last date for On-Market Renunciation of Rights Entitlements was Tuesday, 13th January, 2026. Out of the total 2961 Applications for 46,23,20,738 Rights Equity Shares, 988 Applications for 33,78,888 Rights Equity Shares were rejected due to technical reason, Nil Rights Equity Shares were partially rejected as disclosed in the Basis of allotment approved by BSE Limited ('BSE'). The total number of valid Applications received were 1,973 Applications for 45,89,41,850 Rights Equity Shares. Final subscription is 128.57% after removing rejection of Rights Equity Shares under the Issue.

In accordance with the Letter of Offer and the Basis of Allotment finalized on 21st January, 2026, in consultation with the Registrar to the Issue ('RTA') and BSE Limited ('BSE'), the Designated Stock Exchange, the Rights Issue Committee allotted 35,69,50,000 Fully Paid-up Rights Equity Shares on 21st January, 2026 to the successful Applicants. All valid Applications have been considered for allotment.

1. The break-up of valid applications received through ASBA is as under:

|Applicants|No. of applicants|No. of Equity Shares allotted against REs|No. of Rights Equity Shares allotted against valid additional shares|Total Equity Shares allotted|
|-|-|-|-|-|
|Eligible Equity Shareholders|1,675|4,00,08,625|5,06,35,625|9,06,44,251|
|Renouncees|298|2,21,51,661|24,41,54,088|26,63,05,749|
|\*\*Total\*\*|\*\*1,973\*\*|\*\*6,21,60,287\*\*|\*\*29,47,89,713\*\*|\*\*356,9,50,000\*\*|


2. Information regarding total applications received
Summary of Allotment in various categories is as under:

|Category|Gross|||Less: Rejections / Partial Amount|||Valid|||
|-|-|-|-|-|-|-|-|-|-|
||Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|
|Eligible Equity Shareholders|1,724|9,12,24,685|9,12,24,685.00|49|5,80,434|5,80,434.00|1,675|90,64,4251|90,64,4251.00|
|Fraction|0|0|0.00|0|0|0.00|0|0|0.00|
|Renouncees|308|3,68,419,099|36,84,19,099.00|10|1,21,500|1,21,500.00|298|36,82,97,599|36,82,97,599.00|
|Not an eligible equity Shareholders of the company|929|26,76,954|26,76,954.00|929|26,76,954|26,76,954.00|0|0|0|
|\*\*Total\*\*|\*\*2,961\*\*|\*\*46,23,20,738\*\*|\*\*46,23,20,738.00\*\*|\*\*988\*\*|\*\*33,78,888\*\*|\*\*33,78,888.00\*\*|\*\*1,973\*\*|\*\*45,89,41,850\*\*|\*\*1,39,03,47,024.00\*\*|


Intimation for Allotment/ refund/ rejection cases: The dispatch of allotment advice cum refund intimation and intimation for rejection, as applicable, to the Investors has been completed on 22nd January, 2026. The instructions to SCSBs for unblocking of funds were given on, 21st January, 2026. The listing application was filed with BSE on 22nd January, 2026 and subsequently, the listing approval was received on 22nd January, 2026 from BSE. The credit of Rights Equity Shares in dematerialised form to respective demat accounts of Allottees was completed on 22nd January, 2026 by CDSL and NSDL respectively. For further details, see "Terms of the Issue - Allotment advice or refund/unblocking of ASBA accounts" on page no. 159 of the Letter of Offer. The trading in fully paid-up equity shares issued by way of Rights shall commence on BSE under ISIN - INE183U01022 upon receipt of trading permission. The trading is expected to commence on or about 28th January, 2026.

Further, in accordance with SEBI circular bearing reference - SEBI/HO/CFD/DIL2/CIR/P/2020/13 dated January 22, 2020, the request for extinguishment of Rights Entitlements has been sent to NSDL & CDSL on or before 22nd January, 2026.

**INVESTORS MAY PLEASE NOTE THAT THE EQUITY SHARES CAN BE TRADED ON THE STOCK EXCHANGE IN DEMATERIALISED FORM**

**DISCLAIMER CLAUSE OF BSE (DESIGNATED STOCK EXCHANGE):** It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the Letter of Offer has been cleared or approved by BSE Limited, nor does it certify the correctness or completeness of any of the contents of the Letter of Offer. The investors are advised to refer to the Letter of Offer for the full text of the "Disclaimer Clause of BSE" on page no. 130 of the Letter of Offer.

Unless otherwise specified, all capitalized terms used herein shall have same meaning ascribed to such terms in the Letter of Offer.

|REGISTRAR TO THE ISSUE|COMPANY SECRETARY AND COMPLIANCE OFFICER|
|-|-|


| :--- | :---


WWW.FINANCIALEXPRESS.COM
SUNDAY, JANUARY 25, 2026
19

# FE SUNDAY

## CELLA SPACE LIMITED
CIN: L93000KL1991PLC006207
57/2993-94, Sree Kailas, Pallam Road, Ernakulam, Kochi -16

### EXTRACT OF UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 31st DECEMBER 2025
(Rs in lakhs)

|PARTICULARS|STANDALONE|||
|-|-|-|-|
||Unaudited Quarter ending 31.12.2025|Unaudited 9 months Ended 31.12.2025|Unaudited Corresponding 3 months ended in previous year 31.12.2024|
|Total Income from Operations (net)|72.44|508.13|88.90|
|Net Profit/ (loss) from ordinary activities before tax|13.67|187.83|22.53|
|Net Profit/ (loss) for the period after tax|(43.48)|130.68|22.53|
|Total Comprehensive income for the period and other comprehensive income (after tax)|(43.48)|130.68|22.53|
|Equity Share capital|2,015.12|2,015.12|2,015.12|
|Reserves (Excluding revaluation reserve)|-|-|-|
|Earnings per share (Rs.10/- each)) - Basic|(0.22)|0.65|0.11|
|- Diluted|(0.22)|0.65|0.11|
|Revenue from Operations|11.69|215.40|16.89|
|Less : Direct Expenses|1.78|8.98|1.33|
|Revenue from operations (net)|9.91|206.42|15.56|


Note : The above is an extract of the detailed format of quarterly/annual financial results file with the Stock exchange and regulation 33 of the SEBI (listing and other disclosure requirements), regulations, 2015. the full format of the quarterly/annual financial results are available on the Stock exchange website www.bseindia.com.

For Cella Space Limited
Sd/-,
S Rajkumar
Vice Chairman and Managing Director

Place : Chennai
Date : 23.01.2026

## OneSource Specialty Pharma Limited
(formerly known as Stelis Biopharma Limited)
Registered Office : Unit no. 902, "Cyber One" situated at Plot no.-4 & 6, Sector 30A, Vashi, Navi Mumbai-400703
Corporate Office : Star 1, Opp IIM Bangalore, Bilekahalli, Bannerghatta Road, Bangalore - 560076, India
CIN: L74140MH2007PLC432497, Website : https://www.onesourcedmo.com, Mail: info@onesourcedmo.com

### UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2025
(₹ in Million)

||Sr No|Particulars|Consolidated||||Standalone||||
|-|-|-|-|-|-|-|-|-|-|-|
|||Quarter ended|Nine months period ended|Year ended||Quarter ended|Nine months period ended|Year ended|||
|||31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2024 (Unaudited)|31.03.2025 (Audited)|31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2025 (Unaudited)|
|1|Revenue from Operations|2,903.40|3,757.63|3,925.63|9,933.73|10,189.00|14,448.53|2,902.20|3,751.07|3,367.49|
|2|Net Profit/ (Loss) for the period (before Tax, Exceptional and/ or Extraordinary items)|(859.21)|57.41|340.21|(817.09)|(397.23)|437.79|(550.95)|371.01|275.00|
|3|Net Profit/ (Loss) for the period after tax (Before Exceptional and/ or Extraordinary items and discontinued operations)|(816.09)|104.85|316.74|(684.40)|(56.28)|935.64|(550.95)|371.01|275.00|
|4|Net Profit/ (Loss) for the period after tax (after Exceptional and/ or Extraordinary items and discontinued operation)|(886.99)|104.85|(688.49)|(784.00)|(1,164.73)|(179.71)|(621.85)|371.01|(730.23)|
|5|Earnings Per Share (of Re.1/- each) (for continuing and discontinued operations) -||||||||||
||1. Basic:|(7.74)|0.92|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|
||2. Diluted:|(7.74)|0.91|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|


Note: The above is an extract of the detailed format of the Unaudited Statement of Consolidated and Standalone Financials Results filed with the Stock Exchanges under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The full format of the Consolidated and Standalone Financials Results for the quarter and nine months ended December 31, 2025 is available on the website of Stock Exchanges at www.bseindia.com and www.nseindia.com and also on the Company's website at www.onesourcedmo.com. The same can be accessed by scanning the QR code provided below.

By order of the Board
Sd/-,
Neeraj Sharma
Managing Director
DIN: 09402652
Place: Bengaluru
Date : January 23, 2026

# nuvama
## NUVAMA WEALTH MANAGEMENT LIMITED

Corporate Identity Number : L6710MH1993PLC344634
Registered. Office: 801 - 804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051
• +91 22 6620 3030 • Website: www.nuvama.com

### Financial results for the quarter and nine months ended December 31, 2025
(₹ in Crore, except per share data)

||Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)||
|1 Total income from operations|1,105.98|1,137.93|1,034.99|3,368.52|3,044.51|4,169.30||
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|253.62|253.98|251.71|771.47|729.79|985.06||
|5 Total Comprehensive Income for the period \[Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income (after tax)]|254.66|254.49|251.66|773.50|730.66|984.52||
|6 Paid-up equity share capital (Face Value of ₹ 2/- Per Share)|36.36|36.06|35.88|36.36|35.88|35.97||
|7 Reserves (excluding Revaluation Reserves)|3,780.82|3,733.92|3,157.96|3,780.82|3,157.96|3,434.78||
|8 Securities premium account|1,698.08|1,646.40|1,615.67|1,698.08|1,615.67|1,630.59||
|9 Net worth¹|3,839.14|3,792.43|3,216.34|3,839.14|3,216.34|3,493.11||
|10 Paid-up Debt Capital / Outstanding Debt²|9,964.72|8,974.85|7,552.61|9,964.72|7,552.61|7,838.83||
|11 Outstanding redeemable preference shares|-|-|-|-|-|-||
|12 Debt Equity Ratio³|2.60|2.37|2.35|2.60|2.35|2.24||
|13 Earnings Per Share (₹) (Face Value of ₹ 2/- each)||||||||
||- Basic (Refer note 5 and 6)|14.02|14.11|14.08|42.79|41.10|55.33|
||- Diluted (Refer note 5 and 6)|13.62|13.63|13.71|41.57|40.01|53.71|
|14 Capital Redemption Reserve|20.96|20.96|20.96|20.96|20.96|20.96||
|15 Debenture Redemption Reserve|8.50|19.09|13.29|8.50|13.29|19.09||
|16 Debt Service Coverage Ratio⁴|0.06|0.06|0.07|0.16|0.19|0.25||
|17 Interest Service Coverage Ratio⁵|2.43|2.46|2.52|2.46|2.64|2.64||


¹ Net worth = Equity share capital + Other equity + Non controlling interests
² Paid-up Debt Capital / Outstanding Debt = Debt securities + Borrowings (other than debt securities)
³ Debt-equity Ratio = Total debt (Debt securities + Borrowings (other than debt securities)) / Net worth
⁴ Debt Service Coverage Ratio = (Profit before tax and Finance cost excluding IND AS 116 impact) / (Finance cost excluding IND AS 116 impact + Total Debt)
⁵ Interest Service Coverage Ratio = Profit before tax and Finance cost excluding IND AS 116 impact / Finance cost excluding IND AS 116 impact

Notes:
1. The above is an extract of the detailed format of quarter and nine months ended December 31, 2025 consolidated financial results filed with the Stock Exchanges in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the 'Listing Regulations, 2015') and the Accounting Standards specified under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the relevant provision of the Companies Act, 2013, as applicable. The full format of the standalone and consolidated financial results are available on the website of BSE Limited ('BSE') (www.bseindia.com), National Stock Exchange of India Limited ('NSE') (www.nseindia.com) and Company's website (www.nuvama.com).
2. For the other line items referred in regulation 52 (4) of the Listing Regulations, pertinent disclosures have been made to the Stock Exchanges.
3. The above consolidated financial results of the Company and its subsidiaries (together referred to as 'Group') and its associate and joint venture for the quarter and nine months ended December 31, 2025 have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meetings held on January 23, 2026.
4. The above consolidated financial results for the quarter and nine months ended December 31, 2025 have been subjected to limited review by the Statutory Auditors of the Company and the auditors have issued an unmodified review report.
5. Earnings per share for the quarter and nine months ended are not annualised.
6. The Board of Directors of the Company, at its meeting held on November 04, 2025, approved the sub-division of each equity share having a face value of ₹10/- (Rupees Ten only), fully paid-up, into 5 (five) equity shares having a face value of ₹2/- (Rupees Two only), fully paid-up. Subsequently, the approval of the shareholders was obtained through a postal ballot on December 07, 2025. Consequently, with effect from the Record Date of December 26, 2025, the authorised share capital and paid-up share capital of the Company have been sub-divided into equity shares of face value ₹2/- each. The Earnings Per Share (EPS) for the current and comparative periods have been adjusted/restated appropriately.
7. Standalone financial information of the Company, pursuant to regulation 47(1)(b) of the Listing Regulations, 2015.

(₹ in Crore, except per share data)

|Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)|
|1 Total income from operations|406.50|192.01|385.35|1,024.16|1,136.83|1,357.24|
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|280.29|46.35|206.86|548.12|570.24|597.71|


For and on behalf of the Board of Directors
Sd/-
Ashish Kehair
Managing Director & CEO
DIN: 07789972

Mumbai, January 23, 2026

## PULSAR INTERNATIONAL LIMITED
CORPORATE IDENTIFICATION NUMBER: L46209GJ1990PLC152223

Our Company was originally incorporated as "Arlabs International Private Limited" under the provisions of the Companies Act, 1956, pursuant to a Certificate of Incorporation dated October 15, 1990, issued by the Registrar of Companies, Bombay, Maharashtra. The Company was subsequently converted into a Public Limited Company under the name "Arlabs International Limited", pursuant to a Certificate of Change of Name issued on December 06, 1993 by the Registrar of Companies, Bombay, Maharashtra. The Equity Shares of the Company were listed and admitted to dealings on the Capital Market Segment (Main Board) of BSE Limited on September 26, 1994. Thereafter, the name of the Company was changed to "Pulsar International Limited", pursuant to a Fresh Certificate of Incorporation consequent upon change of name dated May 10, 1996, issued by the Registrar of Companies, Maharashtra. Further, the Registered Office of the Company was shifted from the "State of Maharashtra" to "State of Gujarat" pursuant to an order dated April 26, 2024, passed by the Regional Director and the consequent Certificate of Registration of Regional Director order for change of State dated June 05, 2024, issued by the Registrar of Companies, Ahmedabad. For further details of our Company, please refer to the chapter titled "General Information" on page no. 37 of the Letter of Offer.

Registered Office: 16 Vibrant Mega Industrial Park Survey No. 33, Mouje Vehlal Taluka Daskroi, Vehlal, Ahmedabad, Gujarat, India - 382330
Contact No.: +91-72028 53326, Email id: pulsar.intltd@gmail.com; Website: www.pulsarinternational.co.in;
Contact Person: Ms. Bhumi Sagar Mehta, Company Secretary and Compliance Officer

### OUR PROMOTERS: M/S. BLUEROCK INVESTMENT QUOTIENT LLP

ISSUE OF UPTO 35,69,50,000# FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF RE. 1.00/- EACH ("EQUITY SHARES") OF PULSAR INTERNATIONAL LIMITED ("PULSAR" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RE. 1.00/- PER EQUITY SHARE ("ISSUE PRICE"), AGGREGATING UPTO RS. 35.695 CRORES ON A RIGHTS BASIS TO THE EXISTING EQUITY SHAREHOLDERS OF OUR COMPANY IN THE RATIO OF 5 (FIVE) RIGHTS EQUITY SHARES FOR EVERY 1 (ONE) FULLY PAID-UP EQUITY SHARE HELD BY THE ELIGIBLE EQUITY SHAREHOLDERS ON THE RECORD DATE, MONDAY, 22ND DECEMBER, 2025 (THE "RECORD DATE"). THE ISSUE PRICE IS EQUAL TO THE FACE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE SEE THE CHAPTER TITLED "TERMS OF THE ISSUE" ON PAGE NO. 135 OF THE LETTER OF OFFER.

#ASSUMING FULL SUBSCRIPTION OF THE ISSUE SUBJECT TO FINALISATION OF BASIS OF ALLOTMENT.

### BASIS OF ALLOTMENT

The Board of Directors of our Company thanks all investors for their response to the Issue, which opened for subscription on Wednesday, 31st December, 2025 and closed on Monday, 19th January, 2026 and the last date for On-Market Renunciation of Rights Entitlements was Tuesday, 13th January, 2026. Out of the total 2961 Applications for 46,23,20,738 Rights Equity Shares, 988 Applications for 33,78,888 Rights Equity Shares were rejected due to technical reason, Nil Rights Equity Shares were partially rejected as disclosed in the Basis of allotment approved by BSE Limited ('BSE'). The total number of valid Applications received were 1,973 Applications for 45,89,41,850 Rights Equity Shares. Final subscription is 128.57% after removing rejection of Rights Equity Shares under the Issue.

In accordance with the Letter of Offer and the Basis of Allotment finalized on 21st January, 2026, in consultation with the Registrar to the Issue ('RTA') and BSE Limited ('BSE'), the Designated Stock Exchange, the Rights Issue Committee allotted 35,69,50,000 Fully Paid-up Rights Equity Shares on 21st January, 2026 to the successful Applicants. All valid Applications have been considered for allotment.

1. The break-up of valid applications received through ASBA is as under:

|Applicants|No. of applicants|No. of Equity Shares allotted against REs|No. of Rights Equity Shares allotted against valid additional shares|Total Equity Shares allotted|
|-|-|-|-|-|
|Eligible Equity Shareholders|1,675|4,00,08,625|5,06,35,625|9,06,44,251|
|Renouncees|298|2,21,51,661|24,41,54,088|26,63,05,749|
|\*\*Total\*\*|\*\*1,973\*\*|\*\*6,21,60,287\*\*|\*\*29,47,89,713\*\*|\*\*356,9,50,000\*\*|


2. Information regarding total applications received
Summary of Allotment in various categories is as under:

|Category|Gross|||Less: Rejections / Partial Amount|||Valid|||
|-|-|-|-|-|-|-|-|-|-|
||Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|
|Eligible Equity Shareholders|1,724|9,12,24,685|9,12,24,685.00|49|5,80,434|5,80,434.00|1,675|90,64,4251|90,64,4251.00|
|Fraction|0|0|0.00|0|0|0.00|0|0|0.00|
|Renouncees|308|3,68,419,099|36,84,19,099.00|10|1,21,500|1,21,500.00|298|36,82,97,599|36,82,97,599.00|
|Not an eligible equity Shareholders of the company|929|26,76,954|26,76,954.00|929|26,76,954|26,76,954.00|0|0|0|
|\*\*Total\*\*|\*\*2,961\*\*|\*\*46,23,20,738\*\*|\*\*46,23,20,738.00\*\*|\*\*988\*\*|\*\*33,78,888\*\*|\*\*33,78,888.00\*\*|\*\*1,973\*\*|\*\*45,89,41,850\*\*|\*\*1,39,03,47,024.00\*\*|


Intimation for Allotment/ refund/ rejection cases: The dispatch of allotment advice cum refund intimation and intimation for rejection, as applicable, to the Investors has been completed on 22nd January, 2026. The instructions to SCSBs for unblocking of funds were given on, 21st January, 2026. The listing application was filed with BSE on 22nd January, 2026 and subsequently, the listing approval was received on 22nd January, 2026 from BSE. The credit of Rights Equity Shares in dematerialised form to respective demat accounts of Allottees was completed on 22nd January, 2026 by CDSL and NSDL respectively. For further details, see "Terms of the Issue - Allotment advice or refund/unblocking of ASBA accounts" on page no. 159 of the Letter of Offer. The trading in fully paid-up equity shares issued by way of Rights shall commence on BSE under ISIN - INE183U01022 upon receipt of trading permission. The trading is expected to commence on or about 28th January, 2026.

Further, in accordance with SEBI circular bearing reference - SEBI/HO/CFD/DIL2/CIR/P/2020/13 dated January 22, 2020, the request for extinguishment of Rights Entitlements has been sent to NSDL & CDSL on or before 22nd January, 2026.

**INVESTORS MAY PLEASE NOTE THAT THE EQUITY SHARES CAN BE TRADED ON THE STOCK EXCHANGE IN DEMATERIALISED FORM**

**DISCLAIMER CLAUSE OF BSE (DESIGNATED STOCK EXCHANGE):** It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the Letter of Offer has been cleared or approved by BSE Limited, nor does it certify the correctness or completeness of any of the contents of the Letter of Offer. The investors are advised to refer to the Letter of Offer for the full text of the "Disclaimer Clause of BSE" on page no. 130 of the Letter of Offer.

Unless otherwise specified, all capitalized terms used herein shall have same meaning ascribed to such terms in the Letter of Offer.

|REGISTRAR TO THE ISSUE|COMPANY SECRETARY AND COMPLIANCE OFFICER|
|-|-|


| :--- | :---


WWW.FINANCIALEXPRESS.COM
SUNDAY, JANUARY 25, 2026
19

# FE SUNDAY

## CELLA SPACE LIMITED
CIN: L93000KL1991PLC006207
57/2993-94, Sree Kailas, Pallam Road, Ernakulam, Kochi -16

### EXTRACT OF UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 31st DECEMBER 2025
(Rs in lakhs)

|PARTICULARS|STANDALONE|||
|-|-|-|-|
||Unaudited Quarter ending 31.12.2025|Unaudited 9 months Ended 31.12.2025|Unaudited Corresponding 3 months ended in previous year 31.12.2024|
|Total Income from Operations (net)|72.44|508.13|88.90|
|Net Profit/ (loss) from ordinary activities before tax|13.67|187.83|22.53|
|Net Profit/ (loss) for the period after tax|(43.48)|130.68|22.53|
|Total Comprehensive income for the period and other comprehensive income (after tax)|(43.48)|130.68|22.53|
|Equity Share capital|2,015.12|2,015.12|2,015.12|
|Reserves (Excluding revaluation reserve)|-|-|-|
|Earnings per share (Rs.10/- each)) - Basic|(0.22)|0.65|0.11|
|- Diluted|(0.22)|0.65|0.11|
|Revenue from Operations|11.69|215.40|16.89|
|Less : Direct Expenses|1.78|8.98|1.33|
|Revenue from operations (net)|9.91|206.42|15.56|


Note : The above is an extract of the detailed format of quarterly/annual financial results file with the Stock exchange and regulation 33 of the SEBI (listing and other disclosure requirements), regulations, 2015. the full format of the quarterly/annual financial results are available on the Stock exchange website www.bseindia.com.

For Cella Space Limited
Sd/-,
S Rajkumar
Vice Chairman and Managing Director

Place : Chennai
Date : 23.01.2026

## OneSource Specialty Pharma Limited
(formerly known as Stelis Biopharma Limited)
Registered Office : Unit no. 902, "Cyber One" situated at Plot no.-4 & 6, Sector 30A, Vashi, Navi Mumbai-400703
Corporate Office : Star 1, Opp IIM Bangalore, Bilekahalli, Bannerghatta Road, Bangalore - 560076, India
CIN: L74140MH2007PLC432497, Website : https://www.onesourcedmo.com, Mail: info@onesourcedmo.com

### UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2025
(₹ in Million)

||Sr No|Particulars|Consolidated||||Standalone||||
|-|-|-|-|-|-|-|-|-|-|-|
|||Quarter ended|Nine months period ended|Year ended||Quarter ended|Nine months period ended|Year ended|||
|||31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2024 (Unaudited)|31.03.2025 (Audited)|31.12.2025 (Unaudited)|30.09.2025 (Unaudited)|31.12.2024 (Unaudited)|31.12.2025 (Unaudited)|
|1|Revenue from Operations|2,903.40|3,757.63|3,925.63|9,933.73|10,189.00|14,448.53|2,902.20|3,751.07|3,367.49|
|2|Net Profit/ (Loss) for the period (before Tax, Exceptional and/ or Extraordinary items)|(859.21)|57.41|340.21|(817.09)|(397.23)|437.79|(550.95)|371.01|275.00|
|3|Net Profit/ (Loss) for the period after tax (Before Exceptional and/ or Extraordinary items and discontinued operations)|(816.09)|104.85|316.74|(684.40)|(56.28)|935.64|(550.95)|371.01|275.00|
|4|Net Profit/ (Loss) for the period after tax (after Exceptional and/ or Extraordinary items and discontinued operation)|(886.99)|104.85|(688.49)|(784.00)|(1,164.73)|(179.71)|(621.85)|371.01|(730.23)|
|5|Earnings Per Share (of Re.1/- each) (for continuing and discontinued operations) -||||||||||
||1. Basic:|(7.74)|0.92|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|
||2. Diluted:|(7.74)|0.91|(6.31)|(6.85)|(10.68)|(1.63)|(5.43)|3.24|(6.69)|


Note: The above is an extract of the detailed format of the Unaudited Statement of Consolidated and Standalone Financials Results filed with the Stock Exchanges under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The full format of the Consolidated and Standalone Financials Results for the quarter and nine months ended December 31, 2025 is available on the website of Stock Exchanges at www.bseindia.com and www.nseindia.com and also on the Company's website at www.onesourcedmo.com. The same can be accessed by scanning the QR code provided below.

By order of the Board
Sd/-,
Neeraj Sharma
Managing Director
DIN: 09402652
Place: Bengaluru
Date : January 23, 2026

# nuvama
## NUVAMA WEALTH MANAGEMENT LIMITED

Corporate Identity Number : L6710MH1993PLC344634
Registered. Office: 801 - 804, Wing A, Building No. 3, Inspire BKC, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051
• +91 22 6620 3030 • Website: www.nuvama.com

### Financial results for the quarter and nine months ended December 31, 2025
(₹ in Crore, except per share data)

||Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)||
|1 Total income from operations|1,105.98|1,137.93|1,034.99|3,368.52|3,044.51|4,169.30||
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|339.98|339.23|334.08|1,029.93|978.24|1,318.30||
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|253.62|253.98|251.71|771.47|729.79|985.06||
|5 Total Comprehensive Income for the period \[Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income (after tax)]|254.66|254.49|251.66|773.50|730.66|984.52||
|6 Paid-up equity share capital (Face Value of ₹ 2/- Per Share)|36.36|36.06|35.88|36.36|35.88|35.97||
|7 Reserves (excluding Revaluation Reserves)|3,780.82|3,733.92|3,157.96|3,780.82|3,157.96|3,434.78||
|8 Securities premium account|1,698.08|1,646.40|1,615.67|1,698.08|1,615.67|1,630.59||
|9 Net worth¹|3,839.14|3,792.43|3,216.34|3,839.14|3,216.34|3,493.11||
|10 Paid-up Debt Capital / Outstanding Debt²|9,964.72|8,974.85|7,552.61|9,964.72|7,552.61|7,838.83||
|11 Outstanding redeemable preference shares|-|-|-|-|-|-||
|12 Debt Equity Ratio³|2.60|2.37|2.35|2.60|2.35|2.24||
|13 Earnings Per Share (₹) (Face Value of ₹ 2/- each)||||||||
||- Basic (Refer note 5 and 6)|14.02|14.11|14.08|42.79|41.10|55.33|
||- Diluted (Refer note 5 and 6)|13.62|13.63|13.71|41.57|40.01|53.71|
|14 Capital Redemption Reserve|20.96|20.96|20.96|20.96|20.96|20.96||
|15 Debenture Redemption Reserve|8.50|19.09|13.29|8.50|13.29|19.09||
|16 Debt Service Coverage Ratio⁴|0.06|0.06|0.07|0.16|0.19|0.25||
|17 Interest Service Coverage Ratio⁵|2.43|2.46|2.52|2.46|2.64|2.64||


¹ Net worth = Equity share capital + Other equity + Non controlling interests
² Paid-up Debt Capital / Outstanding Debt = Debt securities + Borrowings (other than debt securities)
³ Debt-equity Ratio = Total debt (Debt securities + Borrowings (other than debt securities)) / Net worth
⁴ Debt Service Coverage Ratio = (Profit before tax and Finance cost excluding IND AS 116 impact) / (Finance cost excluding IND AS 116 impact + Total Debt)
⁵ Interest Service Coverage Ratio = Profit before tax and Finance cost excluding IND AS 116 impact / Finance cost excluding IND AS 116 impact

Notes:
1. The above is an extract of the detailed format of quarter and nine months ended December 31, 2025 consolidated financial results filed with the Stock Exchanges in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the 'Listing Regulations, 2015') and the Accounting Standards specified under section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the relevant provision of the Companies Act, 2013, as applicable. The full format of the standalone and consolidated financial results are available on the website of BSE Limited ('BSE') (www.bseindia.com), National Stock Exchange of India Limited ('NSE') (www.nseindia.com) and Company's website (www.nuvama.com).
2. For the other line items referred in regulation 52 (4) of the Listing Regulations, pertinent disclosures have been made to the Stock Exchanges.
3. The above consolidated financial results of the Company and its subsidiaries (together referred to as 'Group') and its associate and joint venture for the quarter and nine months ended December 31, 2025 have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meetings held on January 23, 2026.
4. The above consolidated financial results for the quarter and nine months ended December 31, 2025 have been subjected to limited review by the Statutory Auditors of the Company and the auditors have issued an unmodified review report.
5. Earnings per share for the quarter and nine months ended are not annualised.
6. The Board of Directors of the Company, at its meeting held on November 04, 2025, approved the sub-division of each equity share having a face value of ₹10/- (Rupees Ten only), fully paid-up, into 5 (five) equity shares having a face value of ₹2/- (Rupees Two only), fully paid-up. Subsequently, the approval of the shareholders was obtained through a postal ballot on December 07, 2025. Consequently, with effect from the Record Date of December 26, 2025, the authorised share capital and paid-up share capital of the Company have been sub-divided into equity shares of face value ₹2/- each. The Earnings Per Share (EPS) for the current and comparative periods have been adjusted/restated appropriately.
7. Standalone financial information of the Company, pursuant to regulation 47(1)(b) of the Listing Regulations, 2015.

(₹ in Crore, except per share data)

|Particulars|Quarter ended|||Nine months ended||Year ended|
|-|-|-|-|-|-|-|
||December 31, 2025 (Unaudited)|September 30, 2025 (Unaudited)|December 31, 2024 (Unaudited)|December 31, 2025 (Unaudited)|December 31, 2024 (Unaudited)|March 31, 2025 (Audited)|
|1 Total income from operations|406.50|192.01|385.35|1,024.16|1,136.83|1,357.24|
|2 Net Profit / (Loss) for the period (before Tax, Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|3 Net Profit / (Loss) for the period before Tax (after Exceptional and/or Extraordinary items)|297.19|62.32|219.40|584.61|621.63|658.15|
|4 Net Profit / (Loss) for the period after Tax (after Exceptional and/or Extraordinary items)|280.29|46.35|206.86|548.12|570.24|597.71|


For and on behalf of the Board of Directors
Sd/-
Ashish Kehair
Managing Director & CEO
DIN: 07789972

Mumbai, January 23, 2026

## PULSAR INTERNATIONAL LIMITED
CORPORATE IDENTIFICATION NUMBER: L46209GJ1990PLC152223

Our Company was originally incorporated as "Arlabs International Private Limited" under the provisions of the Companies Act, 1956, pursuant to a Certificate of Incorporation dated October 15, 1990, issued by the Registrar of Companies, Bombay, Maharashtra. The Company was subsequently converted into a Public Limited Company under the name "Arlabs International Limited", pursuant to a Certificate of Change of Name issued on December 06, 1993 by the Registrar of Companies, Bombay, Maharashtra. The Equity Shares of the Company were listed and admitted to dealings on the Capital Market Segment (Main Board) of BSE Limited on September 26, 1994. Thereafter, the name of the Company was changed to "Pulsar International Limited", pursuant to a Fresh Certificate of Incorporation consequent upon change of name dated May 10, 1996, issued by the Registrar of Companies, Maharashtra. Further, the Registered Office of the Company was shifted from the "State of Maharashtra" to "State of Gujarat" pursuant to an order dated April 26, 2024, passed by the Regional Director and the consequent Certificate of Registration of Regional Director order for change of State dated June 05, 2024, issued by the Registrar of Companies, Ahmedabad. For further details of our Company, please refer to the chapter titled "General Information" on page no. 37 of the Letter of Offer.

Registered Office: 16 Vibrant Mega Industrial Park Survey No. 33, Mouje Vehlal Taluka Daskroi, Vehlal, Ahmedabad, Gujarat, India - 382330
Contact No.: +91-72028 53326, Email id: pulsar.intltd@gmail.com; Website: www.pulsarinternational.co.in;
Contact Person: Ms. Bhumi Sagar Mehta, Company Secretary and Compliance Officer

### OUR PROMOTERS: M/S. BLUEROCK INVESTMENT QUOTIENT LLP

ISSUE OF UPTO 35,69,50,000# FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF RE. 1.00/- EACH ("EQUITY SHARES") OF PULSAR INTERNATIONAL LIMITED ("PULSAR" OR THE "COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RE. 1.00/- PER EQUITY SHARE ("ISSUE PRICE"), AGGREGATING UPTO RS. 35.695 CRORES ON A RIGHTS BASIS TO THE EXISTING EQUITY SHAREHOLDERS OF OUR COMPANY IN THE RATIO OF 5 (FIVE) RIGHTS EQUITY SHARES FOR EVERY 1 (ONE) FULLY PAID-UP EQUITY SHARE HELD BY THE ELIGIBLE EQUITY SHAREHOLDERS ON THE RECORD DATE, MONDAY, 22ND DECEMBER, 2025 (THE "RECORD DATE"). THE ISSUE PRICE IS EQUAL TO THE FACE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE SEE THE CHAPTER TITLED "TERMS OF THE ISSUE" ON PAGE NO. 135 OF THE LETTER OF OFFER.

#ASSUMING FULL SUBSCRIPTION OF THE ISSUE SUBJECT TO FINALISATION OF BASIS OF ALLOTMENT.

### BASIS OF ALLOTMENT

The Board of Directors of our Company thanks all investors for their response to the Issue, which opened for subscription on Wednesday, 31st December, 2025 and closed on Monday, 19th January, 2026 and the last date for On-Market Renunciation of Rights Entitlements was Tuesday, 13th January, 2026. Out of the total 2961 Applications for 46,23,20,738 Rights Equity Shares, 988 Applications for 33,78,888 Rights Equity Shares were rejected due to technical reason, Nil Rights Equity Shares were partially rejected as disclosed in the Basis of allotment approved by BSE Limited ('BSE'). The total number of valid Applications received were 1,973 Applications for 45,89,41,850 Rights Equity Shares. Final subscription is 128.57% after removing rejection of Rights Equity Shares under the Issue.

In accordance with the Letter of Offer and the Basis of Allotment finalized on 21st January, 2026, in consultation with the Registrar to the Issue ('RTA') and BSE Limited ('BSE'), the Designated Stock Exchange, the Rights Issue Committee allotted 35,69,50,000 Fully Paid-up Rights Equity Shares on 21st January, 2026 to the successful Applicants. All valid Applications have been considered for allotment.

1. The break-up of valid applications received through ASBA is as under:

|Applicants|No. of applicants|No. of Equity Shares allotted against REs|No. of Rights Equity Shares allotted against valid additional shares|Total Equity Shares allotted|
|-|-|-|-|-|
|Eligible Equity Shareholders|1,675|4,00,08,625|5,06,35,625|9,06,44,251|
|Renouncees|298|2,21,51,661|24,41,54,088|26,63,05,749|
|\*\*Total\*\*|\*\*1,973\*\*|\*\*6,21,60,287\*\*|\*\*29,47,89,713\*\*|\*\*356,9,50,000\*\*|


2. Information regarding total applications received
Summary of Allotment in various categories is as under:

|Category|Gross|||Less: Rejections / Partial Amount|||Valid|||
|-|-|-|-|-|-|-|-|-|-|
||Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|Applications|Equity Shares|Amount|
|Eligible Equity Shareholders|1,724|9,12,24,685|9,12,24,685.00|49|5,80,434|5,80,434.00|1,675|90,64,4251|90,64,4251.00|
|Fraction|0|0|0.00|0|0|0.00|0|0|0.00|
|Renouncees|308|3,68,419,099|36,84,19,099.00|10|1,21,500|1,21,500.00|298|36,82,97,599|36,82,97,599.00|
|Not an eligible equity Shareholders of the company|929|26,76,954|26,76,954.00|929|26,76,954|26,76,954.00|0|0|0|
|\*\*Total\*\*|\*\*2,961\*\*|\*\*46,23,20,738\*\*|\*\*46,23,20,738.00\*\*|\*\*988\*\*|\*\*33,78,888\*\*|\*\*33,78,888.00\*\*|\*\*1,973\*\*|\*\*45,89,41,850\*\*|\*\*1,39,03,47,024.00\*\*|


Intimation for Allotment/ refund/ rejection cases: The dispatch of allotment advice cum refund intimation and intimation for rejection, as applicable, to the Investors has been completed on 22nd January, 2026. The instructions to SCSBs for unblocking of funds were given on, 21st January, 2026. The listing application was filed with BSE on 22nd January, 2026 and subsequently, the listing approval was received on 22nd January, 2026 from BSE. The credit of Rights Equity Shares in dematerialised form to respective demat accounts of Allottees was completed on 22nd January, 2026 by CDSL and NSDL respectively. For further details, see "Terms of the Issue - Allotment advice or refund/unblocking of ASBA accounts" on page no. 159 of the Letter of Offer. The trading in fully paid-up equity shares issued by way of Rights shall commence on BSE under ISIN - INE183U01022 upon receipt of trading permission. The trading is expected to commence on or about 28th January, 2026.

Further, in accordance with SEBI circular bearing reference - SEBI/HO/CFD/DIL2/CIR/P/2020/13 dated January 22, 2020, the request for extinguishment of Rights Entitlements has been sent to NSDL & CDSL on or before 22nd January, 2026.

**INVESTORS MAY PLEASE NOTE THAT THE EQUITY SHARES CAN BE TRADED ON THE STOCK EXCHANGE IN DEMATERIALISED FORM**

**DISCLAIMER CLAUSE OF BSE (DESIGNATED STOCK EXCHANGE):** It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the Letter of Offer has been cleared or approved by BSE Limited, nor does it certify the correctness or completeness of any of the contents of the Letter of Offer. The investors are advised to refer to the Letter of Offer for the full text of the "Disclaimer Clause of BSE" on page no. 130 of the Letter of Offer.

Unless otherwise specified, all capitalized terms used herein shall have same meaning ascribed to such terms in the Letter of Offer.

|REGISTRAR TO THE ISSUE|COMPANY SECRETARY AND COMPLIANCE OFFICER|
|-|-|


| :--- | :---

